Association For Molecular Pathology et al v. United States Patent and Trademark Office et al

Filing 246

DECLARATION of LAURA A. CORUZZI in Support re: 152 MOTION for Summary Judgment.. Document filed by Myriad Genetics, Lorris Betz, Roger Boyer, Jack Brittain, Arnold B. Combe, Raymond Gesteland, James U. Jensen, John Kendall Morris, Thomas Parks, David W. Pershing, Michael K. Young. (Attachments: # 1 Exhibit 1 Part 1 of 2, # 2 Exhibit 1 Part 2 of 2, # 3 Exhibit 2, # 4 Exhibit 3 Part 1 of 2, # 5 Exhibit 3 Part 2 of 2, # 6 Exhibit 4, # 7 Exhibit 5 Part 1 of 4, # 8 Exhibit 5 Part 2 of 4, # 9 Exhibit 5 Part 3 of 4, # 10 Exhibit 5 Part 4 of 4)(Poissant, Brian)

Association For Molecular Pathology et al v. United States Patent and Trademark Office et al

Doc. 246

UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK ASSOCIATION FOR MOLECULAR PATHOLOGY; AMERICAN COLLEGE OF MEDICAL GENETICS; AMERICAN SOCIETY FOR CLINICAL PATHOLOGY; COLLEGE OF AMERICAN PATHOLOGISTS; HAIG KAZAZIAN, MD; ARUPA GANGULY, PhD; WENDY CHUNG, MD, PhD; HARRY OSTRER, MD; DAVID LEDBETTER, PhD; STEPHEN WARREN, PhD; ELLEN MATLOFF, M.S.; ELSA REICH, M.S.; BREAST CANCER ACTION; BOSTON WOMEN'S HEALTH BOOK COLLECTIVE; LISBETH CERIANI; RUNI LIMARY; GENAE GIRARD; PATRICE FORTUNE; VICKY THOMASON; KATHLEEN RAKER, Plaintiffs, v. UNITED STATES PATENT AND TRADEMARK OFFICE; MYRIAD GENETICS; LORRIS BETZ, ROGER BOYER, JACK BRITTAIN, ARNOLD B. COMBE, RAYMOND GESTELAND, JAMES U. JENSEN, JOHN KENDALL MORRIS, THOMAS PARKS, DAVID W. PERSHING, and MICHAEL K. YOUNG, in their official capacity as Directors of the University of Utah Research Foundation, Defendants. 1. ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

No. 09 Civ. 4515 (RWS)

ECF Case DECLARATION OF LAURA A. CORUZZI

I am a member of the bar of this Court and a member of the law firm of Jones Day. Jones Day is counsel in this action to defendants Myriad Genetics, Lorris Betz, Roger Boyer, Jack Brittain, Arnold B. Combe, Raymond Gesteland, James U. Jensen, John Kendall Morris, Thomas Parks, David W. Pershing and Michael K. Young.

Dockets.Justia.com

2.

I offer this declaration in support of the foregoing defendants' reply to plaintiffs' opposition to Myriad's motion for summary judgment.

3.

Attached hereto as Exhibit 1 is a true and correct copy of sections of the file histories corresponding to U.S. Patent Nos. 5,709,999, 5,710,001, 5,753,441, and 6,033,857. Included documents are: (a) (b) Cover Sheet and the Notice of Allowability from the file history for U.S. Patent No. 5,709,999 (pp. 1-7). Cover Sheet, Amendment filed September 12, 1996, and the Notice of Allowability from the file history for U.S. Patent No. 5,710,001 (pp. 823). Cover Sheet and the Notice of Allowability from the file history for U.S. Patent No. 5,753,441 (pp. 24-32). Cover Sheet and the Notice of Allowability with the Examiner's Amendment from the file history for U.S. Patent No. 6,033,857 (pp. 3342).

(c) (d)

4.

Attached hereto as Exhibit 2 is a true and correct copy of Patrice Watson et al., Detecting BRCA2 Protein Truncation in Tissue Biopsies to Identify Breast Cancers That Arise in BRCA2 Gene Mutation Carriers, 27(24) J. CLIN. ONCOL., 3894 (2009).

5.

Attached hereto as Exhibit 3 is a true and correct copy of International Patent Application No. PCT/US2008/080358 (WO 2009/052417).

6.

Attached hereto as Exhibit 4 is a true and correct copy of Amir A. Jazaeri et al., Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers, 94(13) J. Natl. Cancer Inst., 990 (2002).

CERTIFICATE OF SERVICE This is to certify that on January 29, 2010, a true and correct copy of the foregoing document has been served on all counsel of record via the court's ECF system.

/s/ Brian M. Poissant Brian M. Poissant

25